Preeya Kshettry Gupta MD
Anterior Segment Related, Cataract Related, Cornea & External Disease, Refractive Surgery
Assistant Professor of Ophthalmology, Duke University School of Medicine
Join to View Full Profile
9650 Brier Creek PkwySte 103Raleigh, NC 27617
Phone+1 919-391-7224
Fax+1 919-660-5070
Dr. Gupta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Ophthalmology, 2007 - 2010
Loyola Medicine MacNeal HospitalInternship, Transitional Year, 2006 - 2007
Northwestern University The Feinberg School of MedicineClass of 2006
Certifications & Licensure
SC State Medical License 2023 - 2027
NC State Medical License 2007 - 2025
MN State Medical License 2010 - 2012
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Early Effects of Perfluorohexyloctane Ophthalmic Solution on Patient-Reported Outcomes in Dry Eye Disease: A Prospective, Open-Label, Multicenter Study.Jason Bacharach, Shane R Kannarr, Anthony Verachtert, Preeya K Gupta, Moataz Razeen
Ophthalmology and Therapy. 2025-04-01 - Patient-Reported Burden of Illness and Unmet Needs inblepharitis.Preeya K Gupta, Vance Thompson, Leslie O'Dell, Anh N Ho, Arthur Chan
Patient Preference and Adherence. 2025-01-01 - Internal validation of a convolutional neural network pipeline for assessing meibomian gland structure from meibography.Charles Scales, John Bai, David Murakami, Joshua Young, Daniel Cheng
Optometry and Vision Science. 2025-01-01
Authored Content
- Meibomian Gland Atrophy in Children More Common Than Previously DescribedJune 2018
Press Mentions
Alcon Showcases Five Innovations Across Multiple Specialty Areas at ASCRS 2025April 17th, 2025- CSF-1 Low-Dose Pilocarpine Improves Vision Outcomes in PresbyopiaNovember 12th, 2024
- Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye DiseaseMay 21st, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
